Founded: 2006
Parent company: Publicis Healthcare Communications Group, 1675 Broadway
Officers: Kathy Magnuson, Managing Director; David Grillo, Executive Creative Director, Art; Noel Castro, Executive Creative Director, Copy.
Healthcare accounts: Galderma: Differin, Metrogel 1% TriLuma Cream; Pliaglis, Epiduo; ConvaTec: corporate promotion, Wound Therapeutics, Skin Care, Ostomy Care, FlexiSeal FMS, UrAssist; sanofi-aventis: Allegra D, Nasacort; Sciele: Allegra AOS, Larx, OraPred, Methylin; Teva: TEV-Tropin; King Pharmaceuticals: thrombin JMI.
Accounts gained (3): ConvaTec: converted from project basis to global AOR; Sciele: Larx, OraPred, Methylin; Galderma: Epiduo, Pliaglis.
Accounts lost (2): Abbott Infant Nutritionals: Similac Infant Formulas; Centocor: Remicade.
Services: Digital, DTC, patient communications.
U.S. billings breakdown by media/source:| Medium | 2007 | 2006 |
| Professional Ads | 35.0% | 45.0% |
|
| Sales materials | 55.0% | 50.0% |
| DTC print | 3.0% | 3.0% |
| DTC broadcast | 2.0% | 2.0% |
| Digital marketing | 3.0% | 0.0% |
| Sales force motivation | 2.0% | 0.0% |
New Hire Detail: Daniel Hackett, HR Director; Micahel Ingenthron, Finance Director.
Featured Work
Product: Corporate
Client: ConvaTec
Creative/account team: Ed Nathan, Executive Creative Director-PHCG Global Trust; Grant King, ACD, Art; Jill Zaklow, Group Copy Supervisor; Roy Scott, ACD Art.
Why this ad is special: The goal was to establish a clear global vision highlighting ConvaTec's investment in new approaches to wound, ostomy, and incontinence care. ConvaTec's innovation is collaborative, driven by dialogue with its primary customers. A new global corporate campaign featuring illuminated string figures represents ConvTec's simple yet collaborative approach to product development. WIth ConvaTec's recent acquisition by new ownership, the time is ideal for a new, distinct identity.